|
시장보고서
상품코드
2112460
초음파 바늘 가이드 : 시장 인사이트, 경쟁 구도 및 시장 예측(-2034년)Ultrasound Needle Guides - Market Insights, Competitive Landscape, and Market Forecast - 2034 |
||||||
DelveInsight
초음파 바늘 가이드는 초음파 트랜스듀서에 부착되는 기계식 또는 추적 기능이 있는 부착물로, 영상 유도 하의 중재 시술에서 바늘의 고정된 예측 가능한 경로를 확립하는 장치입니다. 바늘 가이드는 바늘을 초음파 빔 면 내에 정렬함으로써, 비유도식 자유 손 기술과 비교하여 시술 시간 단축, 바늘 끝의 실시간 가시성 향상, 재삽입 시도 횟수 감소 및 합병증 위험 감소를 실현합니다. 초음파 유도 하의 중재적 시술은 병상에서의 혈관 접근부터 전립선 및 간 생검실에 이르기까지 광범위한 임상 현장에서 이루어지고 있으므로, 스폰서 및 병원 시스템은 전문 액세서리 제조업체와 다각화된 초음파 OEM 업체들이 공급하는 프로브 전용 재사용 가능 브래킷,일회용 인서트, 그리고 멸균 처리된 시술 키트로 구성된 광범위한 생태계에 의존하고 있습니다. 이 시장은 제품 유형별로 재사용 가능, 일회용, 멸균, 비멸균 가이드로 분류됩니다. 또한, 바늘 유도 메커니즘별로는 면내, 면외, 각도 조절 가능, 고정 각도 시스템으로 분류됩니다. 더불어, 용도별로는 생검 시술을 필두로, 마취 및 신경 차단, 천자 시술, 통증 관리 등이 있습니다. 최종 사용자별로는 병원 및 진료소를 비롯해 외래수술센터(ASC), 영상 진단센터 등이 있습니다. 전 세계적으로 증가하는 암 및 만성 질환의 부담,외래 및 중환자 치료 현장에서의 포인트 오브 케어 초음파 보급, 그리고 AI를 활용한 경로 매핑 및 전자기 추적 기술의 지속적인 혁신에 힘입어, 초음파 바늘 가이드는 안전하고 효율적인 영상 유도 의료를 뒷받침하는 필수적이고 사용 빈도가 높은 액세서리 카테고리로 자리매김하고 있습니다.
초음파 바늘 가이드 시장의 주요 성장 동인
초음파 바늘 유도 시장의 성장에 기여하는 요인
시장 성장 촉진요인
초음파 유도 하 중재 시술 건수 증가
초음파 바늘 유도 시장의 가장 강력한 시장 성장 촉진요인은 초음파 유도 하 진단 및 중재 시술 건수가 지속적으로 증가하고 있다는 점입니다. 초음파 유도는 CT나 MRI 유도보다 비용이 저렴하면서도 이온화 방사선을 사용하지 않고 실시간 시각화를 실현하기 때문에 현재는 광범위한 생검, 체액 흡인, 카테터 삽입 및 국소 마취 시술에서 임상 표준이 되었습니다. 미국암협회(American Cancer Society)의 예측에 따르면, 2025년 한 해 동안만 미국 내에서 200만 명 이상의 신규 암 환자가 발생할 것으로 예상되며, 각 진단 과정에서는 일반적으로 영상 유도 하 생검을 통한 조직 확인이 필요합니다. 종양학, 비뇨기과, 간내과 및 혈관 접근 분야에서 시술 건수가 증가함에 따라 재사용 가능한 브래킷과 일회용 가이던스 인서트의 소비량이 직접적으로 증가하여 2034년까지 시장 성장을 뒷받침할 것입니다.
만성 질환 유병률 증가 및 고령화
암, 심혈관 질환, 당뇨병으로 인한 전 세계 질병 부담이 증가함에 따라, 니들 가이드가 뒷받침하는 정밀하고 저침습적인 중재 시술에 대한 수요가 확대되고 있습니다. 고령화가 진행되고 동반 질환을 가진 환자층에서 전립선, 간, 유방, 갑상선 생검은 물론, 혈관 접근 및 투석 카테터 삽입은 합병증과 재시도를 줄이기 위해 안정적인 바늘 경로에 의존하고 있습니다. 선진국 및 신흥 시장을 막론하고 만성 질환의 유병률과 고령 인구가 지속적으로 증가함에 따라, 가이드 하 시술 건수 및 이를 뒷받침하는 부속품 수요도 이에 따라 확대되어 장기적이고 지속적인 수요를 지탱하고 있습니다.
포인트 오브 케어 초음파(POCUS)의 급속한 보급
응급 의료, 중환자 치료, 마취과 및 외래 진료 분야에서 소형 포인트 오브 케어 초음파(POCUS) 시스템의 보급이 확대됨에 따라, 바늘 유도 시술의 적용 범위는 기존의 영상의학과를 훨씬 넘어 확장되고 있습니다. POCUS의 도입으로 인해, 방사선과 의사 이외의 임상의(그 수는 증가 추세에 있습니다)에 의한 병상에서의 혈관 접근, 신경 차단 및 천자 시술이 지원되고 있습니다. 이러한 임상의들은 시술을 표준화하고 첫 시술 성공률을 높이기 위해, 저비용이며 착용이 용이한 일회용 가이드에 의존하고 있습니다. POCUS 플랫폼이 의료 현장 전반에 걸쳐 계속 보급됨에 따라, 초음파 유도 시술의 이러한 분산화는 예측 기간 동안 가이드 판매량에 구조적인 호재가 될 것입니다.
시장 제약 요인
꾸준한 성장세에도 불구하고, 초음파 바늘 가이드 시장은 중대한 제약에 직면해 있습니다. 경쟁하는 초음파 기기 제조업체들 사이에서 프로브 전용 브래킷 및 가이드의 설계가 난립하면서 호환성의 파편화가 발생하고 있으며, 액세서리 제조업체는 광범위한 제품 라인을 유지해야 할 필요성에 직면해 있어, 다중 공급업체가 참여하는 병원 시스템에서의 표준화가 복잡해지고 있습니다. 특히 경험이 풍부한 시술자를 중심으로, 특정 시술 건수가 많고 복잡성이 낮은 시술에서는 가이드를 사용하지 않는 프리핸드 기법을 선호하는 경향이 있어, 일부 의료 현장에서는 가이드 장착률이 제한되고 있습니다. 공동구매기구(GPO)나 병원의 조달 통합에 따른 가격 압박으로 인해 범용 일회용 가이드의 이익률은 압박받고 있습니다. 한편, 가이드를 사용한 시술에 대한 보험 환급액은 지역이나 보험 제도에 따라 다릅니다. 각 프로브 전용 구성에 대한 FDA 510(k) 승인 및 국제적인 품질 시스템 인증을 포함한 엄격한 규제 요건으로 인해 제품 개발 기간이 장기화되고, 규정 준수 비용이 증가하고 있습니다. 가격에 민감한 시장이나 신흥 시장에서 추적 기능을 갖춘 프리미엄 가이드 및 재사용 가능한 가이드의 보급 지연에 더해, 특정 고도의 치료 용도에서 로봇 보조 및 정위 내비게이션 플랫폼과 같은 대체 가이드 기술과의 경쟁이 성장을 더욱 억제하고 있습니다. 이러한 호환성, 가격, 규제 및 경쟁 관련 요인들이 복합적으로 작용하여, 시술 건수 증가, POCUS의 보급, 감염 관리에 대한 중시 등 근본적인 성장 요인들이 여전히 견조함에도 불구하고 시장 확대 속도는 완만해지고 있습니다.
Ultrasound Needle Guides Market Summary
An ultrasound needle guide is a mechanical or tracking-enabled accessory attached to an ultrasound transducer that establishes a fixed, predictable trajectory for a needle during image-guided interventional procedures. By keeping the needle aligned within the ultrasound beam plane, needle guides shorten procedure time, improve real-time needle-tip visualization, reduce the number of re-insertion attempts, and lower the risk of complications compared with unguided freehand technique. Because ultrasound-guided interventions span a wide range of clinical settings, from bedside vascular access to prostate and liver biopsy suites, sponsors and hospital systems rely on a broad ecosystem of probe-specific reusable brackets, single-use disposable inserts, and sterile procedure kits supplied by specialized accessory manufacturers and diversified ultrasound OEMs alike. The market is organized by product type across reusable, disposable, sterile, and non-sterile guides; by needle guidance mechanism across in-plane, out-of-plane, adjustable-angle, and fixed-angle systems; by application, led by biopsy procedures alongside anesthesia and nerve blocks, aspiration procedures, and pain management; and by end-user, led by hospitals and clinics alongside ambulatory surgical centers and diagnostic imaging centers. Driven by the rising global burden of cancer and chronic disease, the expansion of point-of-care ultrasound into outpatient and critical-care settings, and continuing innovation in AI-assisted trajectory mapping and electromagnetic tracking, ultrasound needle guides have become an essential, high-frequency accessory category underpinning safe and efficient image-guided care.
Ultrasound Needle Guides Market Key Growth Drivers
Key Companies in Ultrasound Needle Guides Market
The competitive landscape is led by the following active manufacturers:
Factors Contributing to the Growth of the Ultrasound Needle Guides Market
Market Drivers
Rising Volume of Ultrasound-Guided Interventional Procedures
The most powerful driver of the Ultrasound Needle Guides market is the sustained rise in ultrasound-guided diagnostic and interventional procedure volumes. Ultrasound guidance is now the clinical standard for a wide range of biopsies, fluid aspirations, catheter placements, and regional anesthesia procedures, because it delivers real-time visualization without ionizing radiation, at lower cost than CT or MRI guidance. The American Cancer Society projects more than 2 million new cancer diagnoses in the United States in 2025 alone, and each diagnostic pathway typically requires tissue confirmation through image-guided biopsy. As procedure volumes climb across oncology, urology, hepatology, and vascular access, the consumption of both reusable brackets and single-use guidance inserts rises directly, anchoring market growth through 2034.
Growing Prevalence of Chronic Disease and an Aging Population
The rising global burden of cancer, cardiovascular disease, and diabetes is expanding demand for precise, minimally invasive interventions that needle guides support. Prostate, liver, breast, and thyroid biopsies, along with vascular access and dialysis-catheter placement in an aging, comorbid population, depend on stable needle trajectories to reduce complications and repeat attempts. As chronic disease prevalence and the elderly population base continue to grow across developed and emerging markets alike, the underlying volume of guided procedures - and the accessories that support them - expands in step, sustaining durable long-term demand.
Rapid Expansion of Point-of-Care Ultrasound (POCUS)
The proliferation of compact, point-of-care ultrasound systems across emergency medicine, critical care, anesthesiology, and outpatient clinics is broadening the addressable base for needle guides well beyond traditional radiology suites. POCUS adoption supports bedside vascular access, nerve blocks, and aspiration procedures performed by a growing base of non-radiologist clinicians who rely on low-cost, easy-to-attach disposable guides to standardize technique and improve first-pass success. As POCUS platforms continue to proliferate across care settings, this decentralization of ultrasound-guided procedures is a structural tailwind for guide volumes through the forecast period.
Market Restraints
Despite steady momentum, the Ultrasound Needle Guides market faces material constraints. The proliferation of probe-specific bracket and guide designs across competing ultrasound OEMs creates compatibility fragmentation, requiring accessory manufacturers to maintain extensive product lines and complicating standardization for multi-vendor hospital systems. Clinician preference for unguided freehand technique in certain high-volume, low-complexity procedures, particularly among highly experienced operators, limits guide attachment rates in some settings. Pricing pressure from group purchasing organizations and hospital procurement consolidation compresses margins for commodity disposable guides, while reimbursement for the underlying guided procedures varies across geographies and payer systems. Stringent regulatory requirements, including FDA 510(k) clearance and international quality-system certification for each probe-specific configuration, lengthen product-development timelines and raise compliance costs. Slower adoption of premium tracking-enabled and reusable guide categories in price-sensitive and emerging markets, combined with competition from alternative guidance technologies such as robotic-assisted and stereotactic navigation platforms in select high-acuity applications, further tempers growth. Together, these compatibility, pricing, regulatory, and competitive dynamics moderate the pace of expansion, even as the underlying drivers of procedure-volume growth, POCUS adoption, and infection-control preference remain firmly intact.
Ultrasound Needle Guides Market Segment Analysis
The ultrasound needle guides market by product type (reusable ultrasound needle guides, disposable ultrasound needle guides, sterile ultrasound needle guides, non-sterile ultrasound needle guides), needle guidance mechanism (in-plane needle guides, out-of-plane needle guides, adjustable-angle needle guides, fixed-angle needle guides), application (anesthesia & nerve blocks, biopsy procedures, aspiration procedures, pain management, others), end-users (hospitals & clinics, ambulatory surgical centers (ascs), diagnostic imaging centers, others), and geography (North America, Europe, Asia-Pacific, and Rest of World).
By Product Type
Dominant Subsegment: Disposable Ultrasound Needle Guides.
The disposable ultrasound needle guides segment accounted for approximately 74% of the Ultrasound Needle Guides market in 2025. Disposable guides are the leading product type because hospitals and ambulatory facilities increasingly prioritize infection control and eliminate the labor, cost, and turnaround burden of reprocessing between procedures. The two-part design popularized by systems such as CIVCO's Ultra-Pro II, pairing a durable, probe-specific reusable bracket with a sterile, single-use snap-on guide, allows facilities to combine cost efficiency with per-procedure sterility assurance. High-frequency applications such as vascular access, fine-needle aspiration, and regional anesthesia particularly favor disposables given their procedure volume and turnaround requirements. While reusable guides are growing at the fastest rate as tracking-enabled and premium multi-angle systems gain clinical traction in specialized biopsy and interventional-radiology settings, the sheer procedure volume and infection-control preference secure the disposable segment's leadership across the forecast period.
By Needle Guidance Mechanism
Dominant Subsegment: In-Plane Needle Guides.
The in-plane needle guides segment accounted for approximately 57% of the Ultrasound Needle Guides market in 2025. In-plane guidance is the leading mechanism because it keeps the entire needle shaft and tip continuously visible within the ultrasound beam plane throughout advancement, which is the preferred technique for regional anesthesia and nerve block procedures, vascular access, and many superficial biopsy applications where continuous needle-tip visualization is critical to safety. Clinical training programs and professional society guidelines widely favor in-plane technique for novice and experienced operators alike, reinforcing its adoption across hospitals and outpatient settings. Adjustable-angle guides are the fastest-growing mechanism, as they allow clinicians to modify needle trajectory without withdrawing and repositioning the instrument, an increasingly valued feature in prostate and deep-organ biopsy. Out-of-plane and fixed-angle guides retain steady niche demand in specific deep-target and endocavity applications. Nonetheless, the versatility and safety profile of in-plane guidance secure its leadership across the forecast period.
Ultrasound Needle Guides Market Region Analysis
Dominant Region: North America
North America accounted for 36% of the global Ultrasound Needle Guides market revenue in 2025, representing the highest regional market share globally. The region's dominance reflects a mature interventional-radiology and point-of-care ultrasound ecosystem, high per-capita procedure volumes, a dense hospital and ambulatory surgical center network, and clear FDA 510(k) regulatory pathways, particularly in the United States. North America hosts the largest installed base of ultrasound systems from GE HealthCare, Siemens Healthineers, and other major OEMs, and benefits from proximity to leading accessory manufacturers such as CIVCO Medical Solutions, Aspen Surgical, and Argon Medical Devices. Rising cancer screening rates, growing adoption of the transperineal prostate biopsy approach, and expanding point-of-care ultrasound use across emergency medicine and critical care drive substantial guide consumption. Strong reimbursement for image-guided procedures, well-established clinician training infrastructure, and continued product innovation anchor the region's continued leadership across the forecast period.
Fastest Growing Region: Asia-Pacific
Asia-Pacific is the fastest-growing region in the Ultrasound Needle Guides market. The region's elevated CAGR is driven by rising cancer incidence, rapid expansion of hospital and diagnostic imaging infrastructure, and growing healthcare investment across China, Japan, India, South Korea, and Australia. China is expanding its base of installed ultrasound systems and interventional-radiology capacity, Japan is advancing point-of-care ultrasound adoption in outpatient and critical-care settings, India is scaling low-cost biopsy and diagnostic imaging services alongside a growing base of ambulatory surgical centers, and South Korea and Australia are adopting premium tracking-enabled guidance systems in leading academic hospitals. Government healthcare investment, an expanding oncology patient population, and growing local manufacturing by regional OEMs such as Mindray are accelerating adoption, while regional distributors increasingly partner with global accessory manufacturers to broaden probe-specific coverage. The combination of high disease burden, infrastructure build-out, and rising POCUS penetration positions Asia-Pacific as the principal source of incremental growth over the forecast period.
Regional Commentary
North America
North America accounted for 36% of the global Ultrasound Needle Guides market revenue in 2025. The United States dominates on the strength of its interventional-radiology infrastructure, POCUS adoption, FDA regulatory clarity, and proximity to leading accessory manufacturers, while growing transperineal prostate biopsy adoption and expanding point-of-care ultrasound use across emergency and critical care reinforce its leadership.
Europe
Europe is a large and advanced regional market, supported by well-established interventional-radiology and anesthesiology practice, harmonized CE-marking regulatory pathways, and strong clinical adoption of ultrasound-guided regional anesthesia. Product launches and platform-embedded guidance software from Siemens Healthineers and Esaote, alongside distribution reach from CIVCO and Rocket Medical, reinforce the region's role in supplying both hospital and ambulatory procedure settings across Germany, France, the United Kingdom, Italy, and Spain.
Asia-Pacific
Asia-Pacific is the fastest-growing region, propelled by rising cancer incidence, rapid hospital and diagnostic imaging infrastructure build-out, and growing healthcare investment across China, Japan, India, South Korea, and Australia. China's expanding installed ultrasound base, Japan's POCUS adoption, India's low-cost diagnostic imaging scale-up, and growing regional manufacturing by Mindray are accelerating regional guide consumption and clinical-training activity.
Rest of World
The Rest of World region, spanning Latin America, the Middle East, and Africa, is an emerging growth frontier. Expanding hospital and diagnostic imaging infrastructure, rising demand for image-guided biopsy and anesthesia procedures, and gradual alignment of regulatory frameworks with international standards are broadening access, while distributor partnerships with global manufacturers support the build-out of regional procedure capacity.
Ultrasound Needle Guides Market Competitive Landscape
The Ultrasound Needle Guides market is classified as Fragmented. A group of specialized accessory manufacturers with broad probe-compatible portfolios, including CIVCO Medical Solutions, Aspen Surgical, and Argon Medical Devices, hold leading positions through extensive OEM-compatible product lines, while diversified ultrasound system OEMs, including GE HealthCare, Siemens Healthineers, Mindray, and Esaote, compete by embedding guidance and tracking capability directly into their imaging platforms. Focused device makers such as Geotek Medical, Rocket Medical, Becton, Dickinson and Company (BD), and Veran Medical Technologies compete through specialized bracket systems, vascular-access integration, and electromagnetic tracking expertise, respectively, intensifying competition across both the commodity disposable and premium tracking-enabled segments.
The competitive landscape can be evaluated across the following dimensions:
Ultrasound Needle Guides Market Recent Developmental Activities
In 2026, CIVCO Medical Solutions expanded its TP Pivot Pro transperineal biopsy guide portfolio and continued rollout of the Verza and VerzaLink multi-angle needle guidance systems across additional ultrasound transducer families. Strategic significance: Broadens freehand, infection-reducing transperineal biopsy access and reinforces CIVCO's position as the leading probe-compatible accessory provider.
In 2026, Siemens Healthineers acquired a niche needle-tracking technology firm to embed AI-assisted trajectory-mapping software into its Acuson ultrasound platform. Strategic significance: Strengthens platform-embedded guidance capability and extends Siemens Healthineers' premium, tracking-enabled offering.
Ultrasound Needle Guides Market Segmentation
Ultrasound Needle Guides Market by Product Type
Ultrasound Needle Guides Market by Needle Guidance Mechanism
Ultrasound Needle Guides Market by Application
Ultrasound Needle Guides Market by End-Users
Ultrasound Needle Guides Market by Geography
Key Takeaways from the Ultrasound Needle Guides Market Report Study
Target audience who can benefit from this ultrasound needle guides market report study
Q1. What is the growth rate of the ultrasound needle guides market?
The ultrasound needle guides market is projected to expand at a CAGR of 6.2% during the forecast period from 2026-2034.
Q2. What is the market size of the ultrasound needle guides market?
The ultrasound needle guides market is estimated at USD 398 million in 2025 and is projected to reach USD 682 million by 2034.
Q3. Which region dominates the ultrasound needle guides market?
North America dominated the Ultrasound Needle Guides market with a 36% share of global revenue in 2025, supported by a mature interventional-radiology and point-of-care ultrasound ecosystem, high per-capita procedure volumes, FDA regulatory clarity, and proximity to leading accessory manufacturers. Asia-Pacific is the fastest-growing region over the forecast period.
Q4. What are the key drivers of the ultrasound needle guides market?
The principal drivers are the rising global volume of ultrasound-guided interventional procedures, supported by more than 2 million projected new U.S. cancer diagnoses in 2025; the growing prevalence of chronic disease and an aging population; rapid expansion of point-of-care ultrasound (POCUS) across critical care and outpatient settings; rising prostate biopsy incidence and transperineal biopsy adoption; the structural shift toward single-use, infection-controlled accessories; and continuing innovation in AI-assisted and tracking-enabled guidance.
Q5. Who are the major players in the ultrasound needle guides market?
The major players include CIVCO Medical Solutions, Aspen Surgical, Geotek Medical, Rocket Medical, Mindray, Esaote, GE HealthCare, Siemens Healthineers, Becton, Dickinson and Company (BD), and Argon Medical Devices, among other active providers profiled in the Competitive Landscape section, along with Veran Medical Technologies. CIVCO Medical Solutions, Aspen Surgical, and Argon Medical Devices lead through broad probe-compatible product portfolios.
For illustrative purposes, only the top 10 companies are listed in the Table of Contents. The report may include analysis and references to additional companies where relevant to the market assessment.